TREA

90812123 - AI IS WHERE THE DATA IS

Follow

Information

  • Trademark
  • 90812123
  • Serial Number
    90812123
  • Registration Number
    6693951
  • Filing Date
    July 06, 2021
    2 years ago
  • Registration Date
    April 05, 2022
    2 years ago
  • Transaction Date
    November 02, 2022
    a year ago
  • Status Date
    April 05, 2022
    2 years ago
  • Published for Opposition Date
    January 18, 2022
    2 years ago
  • Location Date
    April 05, 2022
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    ANDERSON, CASSONDRA CR
  • Attorney Name
    Anna Kurian Shaw
    Law Office Assigned Location Code
    L30
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
AI IS WHERE THE DATA IS
Case File Statements
  • GS0091: Bioinformatics software; graphical user interface software; artificial intelligence and machine learning software for genome analysis, developing personal treatment strategies for patients with diagnosed cancer, analyzing, screening, identifying, quantifying, and interpreting data in the field of mass spectrometry and next-generation sequencing (NGS); electronic databases for bioinformatic purposes; next-generation sequencing (NGS) data processor; bioinformatics data processor; computer software
  • PM0001: ARTIFICIAL INTELLIGENCE IS WHERE THE DATA IS
  • GS0351: Statistical services and modeling with respect to cancer treatment and cancer diagnosis
  • GS0441: Medical and pharmaceutical services
  • GS0421: Computer programming in the medical, pharmaceutical and biotechnological field; database design; database maintenance; programming of software for importing and managing data; information technology services for the pharmaceutical and healthcare industries; Computer programming for data processing; non-downloadable computer software; conducting evaluations in the field of pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development and evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials in the field of pharmaceuticals for the treatment and prevention of cancer; collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; research and development of medicines and diagnostic agents for cancer treatment and cancer diagnosis; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis in the field of next-generation sequencing (NGS) with respect to the analysis and interpretation of genomic data obtained from cancer patients; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; research and development services in the field of immunology
Case File Event Statements
  • 11/2/2022 - a year ago
    20 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 11/2/2022 - a year ago
    19 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 11/2/2022 - a year ago
    18 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 11/2/2022 - a year ago
    17 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 11/2/2022 - a year ago
    16 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 4/5/2022 - 2 years ago
    15 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 1/18/2022 - 2 years ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/18/2022 - 2 years ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/29/2021 - 2 years ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/11/2021 - 2 years ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/10/2021 - 2 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/10/2021 - 2 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/9/2021 - 2 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 12/6/2021 - 2 years ago
    7 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 9/21/2021 - 2 years ago
    6 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 9/21/2021 - 2 years ago
    5 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 9/21/2021 - 2 years ago
    4 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 9/21/2021 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/14/2021 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 7/9/2021 - 2 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP